CA3236433A1 - Tricyclic heterocycles - Google Patents
Tricyclic heterocycles Download PDFInfo
- Publication number
- CA3236433A1 CA3236433A1 CA3236433A CA3236433A CA3236433A1 CA 3236433 A1 CA3236433 A1 CA 3236433A1 CA 3236433 A CA3236433 A CA 3236433A CA 3236433 A CA3236433 A CA 3236433A CA 3236433 A1 CA3236433 A1 CA 3236433A1
- Authority
- CA
- Canada
- Prior art keywords
- substituted
- alkyl
- unsubstituted
- ring
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21205456 | 2021-10-29 | ||
| EP21205456.3 | 2021-10-29 | ||
| PCT/EP2022/079848 WO2023072974A1 (en) | 2021-10-29 | 2022-10-26 | Tricyclic heterocycles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3236433A1 true CA3236433A1 (en) | 2023-05-04 |
Family
ID=78414452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3236433A Pending CA3236433A1 (en) | 2021-10-29 | 2022-10-26 | Tricyclic heterocycles |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4423091A1 (https=) |
| JP (1) | JP2024540187A (https=) |
| CN (1) | CN118434743A (https=) |
| AU (1) | AU2022378910A1 (https=) |
| CA (1) | CA3236433A1 (https=) |
| IL (1) | IL312303A (https=) |
| WO (1) | WO2023072974A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119968359A (zh) | 2022-09-29 | 2025-05-09 | 英矽智能科技知识产权有限公司 | Tead抑制剂及其使用方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102079255B1 (ko) * | 2013-06-18 | 2020-02-20 | 삼성디스플레이 주식회사 | 헤테로고리 화합물 및 이를 포함한 유기 발광 소자 |
| WO2020096416A1 (ko) * | 2018-11-09 | 2020-05-14 | 한국화학연구원 | Yap-tead 결합을 저해하는 화합물 및 이를 유효 성분으로 함유하는 암의 예방 또는 치료용 약제학적 조성물 |
| JP2023524863A (ja) * | 2020-05-08 | 2023-06-13 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | 三環式のヘテロ環 |
-
2022
- 2022-10-26 CA CA3236433A patent/CA3236433A1/en active Pending
- 2022-10-26 WO PCT/EP2022/079848 patent/WO2023072974A1/en not_active Ceased
- 2022-10-26 IL IL312303A patent/IL312303A/en unknown
- 2022-10-26 EP EP22809743.2A patent/EP4423091A1/en active Pending
- 2022-10-26 AU AU2022378910A patent/AU2022378910A1/en active Pending
- 2022-10-26 CN CN202280085968.1A patent/CN118434743A/zh active Pending
- 2022-10-26 JP JP2024525680A patent/JP2024540187A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022378910A1 (en) | 2024-06-13 |
| CN118434743A (zh) | 2024-08-02 |
| EP4423091A1 (en) | 2024-09-04 |
| JP2024540187A (ja) | 2024-10-31 |
| IL312303A (en) | 2024-06-01 |
| WO2023072974A1 (en) | 2023-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102448958B (zh) | 嘧啶基和1,3,5-三嗪基苯并咪唑磺酰胺和其在癌症治疗中的用途 | |
| AU2019313441B2 (en) | TLR7/8 antagonists and uses thereof | |
| CA2979302A1 (en) | Substituted quinoxaline derivatives | |
| AU2018312836B2 (en) | Novel heterocyclic compounds as CDK8/19 inhibitors | |
| AU2016287335A1 (en) | TBK/IKKepsilon inhibitor compounds and uses thereof | |
| CA3185634A1 (en) | Tricyclic heterocycles | |
| CA3025220A1 (en) | Tricyclic heterocylic derivatives | |
| CA3225045A1 (en) | Her2 mutation inhibitors | |
| WO2021224291A1 (en) | Tricyclic heterocycles useful as tead binders | |
| ES3053012T3 (en) | Condensed pyridine derivatives substitued by amide functions as acss2 inhibitors | |
| CA3236433A1 (en) | Tricyclic heterocycles | |
| CA3180798A1 (en) | Tricyclic heterocycles useful as tead binders | |
| AU2024317622A1 (en) | Substitued bicyclic heterocyclic yap-tead and/or taz-tead inhibitors | |
| CA3237030A1 (en) | Heterobifunctional molecules as tead inhibitors | |
| WO2022233442A1 (en) | 2,8-dihydropyrazolo[3,4-b]indole derivatives for use in the treatment of cancer | |
| CA3175738A1 (en) | Tetrazole derivatives | |
| CA3042988A1 (en) | Substituted quinoxaline derivatives as inhibitors of pfkfb | |
| CA3218932A1 (en) | 2,8-dihydropyrazolo[3,4-b]indole derivatives for use in the treatment of cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 2ND ANNIV.) - STANDARD Year of fee payment: 2 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240904 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240904 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240904 |
|
| P22 | Classification modified |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P22-P110 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CLASSIFICATION MODIFIED Effective date: 20240918 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250925 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250925 |